Senseonics Holdings Inc (SENS) USD0.001
Sell:$0.74Buy:$0.75
$0.02
(2.15%)
- This stock can be held in a
Stocks and Shares ISA$0.02
(2.15%)$0.02
(2.15%)Company Information
About this company
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
Key people
Key facts
- EPICSENS
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS81727U1051
- Market cap$482.22m
- Employees117
- Shares in issue654.22m
- ExchangeNyse American LLC
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.